Adenosine influences the function of several cell types thought to be involved in the pathogenesis of myocardial reperfusion injury. We have previously demonstrated that intracoronary administration of adenosine enhances myocardial salvage 24 hours after reperfusion. To 
We have previously demonstrated that intracoronary administration of adenosine commencing immediately after reperfusion following 90 minutes of regional ischemia in a canine model substantially reduces infarct size and hastens the recovery of postischemic left ventricular dysfunction ("stunning") when measured 24 hours after reperfusion.3 Because some pharmacological interventions may delay the process of myocardial necrosis for hours, it is essential that the effects of the drug be determined over a longer reperfusion period. Furthermore, the clinical applicability of intracoronary administration of drugs would be limited to a few patients. Therefore, we investigated the effects of an intravenous adenosine infusion administered during the early perireperfusion period on infarct size and regional ventricular function in a closed-chest canine model subjected to 90 minutes of proximal left anterior descending artery (LAD) occlusion and 72 hours of reperfusion. Also, the effects of adenosine on serial myocardial blood flow were measured and correlated with ultrastructural changes in the microvasculature of the reperfused bed.
Methods

Experimental Preparation
Twenty-six mongrel dogs of either sex weighing Selective injection of contrast into the left coronary artery via a modified Judkin's catheter confirmed patency of the LAD. Left ventriculography in the right anterior oblique projection with 8-10 ml meglumine diatrizoate (Renografin 76) injected during 1 second through a power injector was performed to confirm normal and uniform wall motion. After each animal received a bolus injection of lidocaine (2 mg/kg) followed by a maintenance infusion at 0.1 mg/kg/min during the occlusion period, the snare was tightened progressively during 5-10 minutes to occlude the proximal LAD and maintained for 90 minutes. Total occlusion was confirmed by selective coronary angiography. Hemodynamic measurements, left ventriculography, and regional myocardial blood flow were repeated after 60 minutes of occlusion. In the treatment group, adenosine (2 mg/ml in 0.9% NaCl) (Sigma Chemical Co., St. Louis) was administered through the Gensini catheter in the inferior vena cava as a continuous infusion at 0.15 mg/kg/min by a Harvard pump beginning 5 minutes before reperfusion and ending 150 minutes after reperfusion. The mean volume administered was 1.5 ml/min for 150 minutes for a total volume of 225 ml (450 mg adenosine). After 90 minutes of LAD occlusion, the snare was gradually released during approximately 3 minutes, followed by selective coronary angiography and determination of regional myocardial blood flow to confirm vessel patency. Hemodynamic measurements and regional blood flow were determined at 1, 2, and 3 hours after reperfusion. Left ventriculography and coronary angiography were again performed at 3 hours of reperfusion after determining regional blood flow. The LAD snare and left atrial catheter were then reimbedded into the subcutaneous pocket, femoral lines were removed, and the vessels were ligated, the animals were weaned from the ventilator, administered antibiotics, and allowed to recover.
After 72 hours, the animals were reanesthetized with pentobarbital. Hemodynamic measurements and left ventriculography were performed, and patency of the LAD was confirmed by selective coronary angiography. A left thoracotomy was performed, and the snare was tightened under direct vision. Monastral blue dye (du Pont, Wilmington, Del.) at a dose of 1 mg/kg was injected into the aortic root through a pigtail catheter within 60 seconds after occluding the vessel. This method provides for a more physiological risk region because when infarction occurs, the bed at risk is not being perfused and therefore has a low flow state. Although in vitro techniques allow injection of colored dyes at fixed pressure in all beds, in vivo methods allow administration of a known volume and viscosity of dye in a situation more analogous to the conditions at the time of previous myocardial ischemia. After a lethal dose of pentobarbital and potassium chloride, the heart was rapidly explanted and rinsed with tap water to prevent counterstaining. Analysis ofArea at Risk and Area of Necrosis The hearts were sectioned into six 1-cm segments parallel to the atrioventricular groove from apex to base and photographed with Ektachrome (Kodak) for later determination of the area at risk (unstained by Monastral blue). The slices not used for blood flow (slices 1, 3, 5, and 6) were then dehydrated. All slices were embedded into paraffin (with the slice facing the apex to be used as the cutting surface) by the method described by Reimer and Jennings.26 Microscopic sections 7 gm thick were cut from the apical end of each slice and stained with hematoxylin and eosin and Mallory's trichrome stain. Using magnified tracings x5 from each slide with the aid of a microscopic slide projector, the area at risk and area of necrosis (stained purple by Mallory's) were then determined by computerized planimetry of the tracings drawn by an observer blinded to the treatment groups. The ratio of the infarcted area to area at risk for each heart was calculated by a method previously described.27
Analysis of Ventricular Function
Global and regional ventricular functions were measured by digitization of an end-systolic and enddiastolic cineangiographic frame. Left ventricular ejection fraction was calculated by Simpson's rule. Regional wall motion was assessed with a radial shortening method using customized software as previously described and validated in our laboratory.27 Radii were constructed from the midpoint of the longitudinal axis connecting the midpoint of the aortic valve plane and the apex of the left ventricle at 100 intervals for a total of 36 radii. Radii that involved the mitral and aortic valves were excluded from analysis. The ischemic zone was defined as the largest number of radii that were akinetic or dyskinetic after 1 hour of occlusion. Ventricular function was also assessed at baseline and 3 and 72 hours after reperfusion.
Determination of Regional Myocardial Blood Flow
The second and fourth transverse myocardial sections were used for determination of regional blood flow. Samples were obtained from the endocardium, midmyocardium, and epicardium (0.15-0.55 g) in the nonischemic zone (posterior wall) and the central and lateral regions of the ischemic zone as demarcated in vivo by Monastral blue dye. These samples and arterial reference samples were counted for 5 minutes in a multichannel autogamma scintillation spectrometer (model 5986, Packard Instrument Company, Downers Grove, Ill.). Background contamination and overlapping radioactivity from other isotopes were accounted for using a matrix correction method (Compusphere Software, Packard Instrument Company) and corrected for microsphere loss and tissue edema.28,29 Samples were averaged for each section, and myocardial blood flow was calculated in milliliters per gram wet weight per minute as previously described in our laboratory.27 Light Microscopy
The first and third sections were stained with hematoxylin and eosin and examined by light microscopy in a blinded manner. The extent of patchy myocardial necrosis, degree of hemorrhage, and extent of contraction band necrosis were evaluated. The acute inflammatory infiltrate within vessels and in the surrounding myocardium (interstitium) and macrophage infiltration was assessed in the ischemic and nonischemic zones. An average of 20 high-power 7 .1+ 1.9% in treated animals, p=0.14). However, analysis of a subset of animals (four adenosine-treated and four controls) with similar areas at risk and collateral blood flows revealed a marked decrease in infarct size when expressed as a percent of the area at risk and when expressed as a percent of the total left ventricle ( Table 3 ). The relation of infarct size expressed as a percentage of area at risk and transmural collateral blood flow in the central ischemic zone 60 minutes into occlusion is shown by linear regression in Figure 2 . A weak relation occurred between these variables for both groups. An inverse relation between infarct size and collateral flow was noted; dogs with high collateral blood flow had smaller infarcts. This graph also suggests that adenosine enhanced myocardial salvage independent of the degree of collateral blood flow.
Effects on Myocardial Blood Flow
Regional myocardial blood flow in the central ischemic zone was similar in the groups at baseline (Figures 3 and 4) . After 60 minutes of occlusion, endocardial blood flow was lower in the adenosinetreated group, although this did not achieve statistical significance (0.06+±0.02 ml/min/g in controls versus 0.01±0.01 ml/min/g in treated animals, p=0.08). This trend suggests the treatment group experienced a greater severity of endocardial ischemia; however, transmural blood flow 60 minutes after occlusion was similar. Both groups exhibited reactive hyperemia during the immediate reperfusion period. During the first 2 hours of adenosine administration a similar enhancement in myocardial blood flow was noted from the subendocardial to the subepicardial region in the ischemic zone. In the control group, a progressive decrease in flow occurred in the endocardial and midmyocardial regions of the central and lateral ischemic zones compatible with the no-reflow phenomenon. In the treated animals, regional blood flow in the inner two thirds of the myocardium was significantly higher than in controls at 3 hours after reperfusion (30 minutes after discontinuation of adenosine infusion) and was similar to the preocclusion value. Regional myocardial blood flows in the lateral ischemic zones were similar to flows in the central ischemic zone throughout the protocol (data not shown). Myocardial Light Microscopy Hearts from 13 control and nine adenosine-treated animals were examined by light microscopy (Table  4) . Acute inflammatory infiltration tended to be less in adenosine-treated animals than in controls (intravascular: 1.07+0.17 in controls versus 0.77+0.14 in treated animals, p=NS; interstitial: 0.84±0.18 in controls versus 0.66 +0.23 in treated animals,p=NS), and no differences were noted between interstitial and intravascular distribution within each animal. Similarly, hemorrhagic infarction was less severe in adenosine animals (1.73±0.36 in controls versus 1.33±0.16 in treated animals, p=NS), and there tended to be greater contraction band necrosis in controls than in adenosine-treated animals. However, because histological parameters were assessed 72 hours after reperfusion, no significant differences in neutrophil infiltration between the two groups were noted. Infarcts were predominantly subendocardial in adenosine-treated animals compared with controls, which had greater degrees of midmyocardial and subepicardial involvement.
Electron Microscopy
A total of 36 specimens from five control and four adenosine-treated animals were examined by electron microscopy ( Figure 6 ). An average of 16 capillaries were examined from each animal from the endocardial and epicardial ischemic region and representative capillaries from nonischemic zones at magnification of x 3,000. Both capillaries and myocyte injury were quantitated from electron photomicrographs using established criteria identified in Table 1 . Endothelial injury was greatest in the subendocardial region of control animals. Animals treated with adenosine had significantly less endothelial injury in the epicardial region (1.22±0.17 in controls versus 0.43+0.07 in treated Experimental studies in the canine model suggest that infarct evolution is virtually complete at 24 hours after permanent coronary occlusion.31 However, pharmacological interventions may delay the process of myocardial necrosis until 24-72 hours in both permanent occlusion and reperfusion models. This phenomenon has been observed with various agents, including calcium channel blockers (verapamil), anti-inflammatory agents (ibuprofen), and the prostacyclin analogue (iloprost). 28, [32] [33] [34] [35] [36] This may be one explanation for the disparate results obtained with the free radical-scavenging enzymes, superoxide dismutase, and catalase because the majority of positive studies occurred in animals killed within 48 hours of reperfusion.37 Numerous other explanations may be responsible for the inconsistent effects of superoxide dismutase on myocardial reperfusion injury; these have been recently summarized by Engler and Gilpin.37 Because animals were killed at 24 hours in our previous study with intracoronary adenosine, it is important to confirm whether the drug had sustained effects on myocardial salvage.3 The present study demonstrates that intravenous adenosine administered during the first 150 minutes of reperfusion results in a persistent reduction in reperfusion injury in the canine model.
Possible Mechanisms ofAction
Although the precise mechanism whereby adenosine attenuated reperfusion injury in the study was not addressed, numerous possibilities exist, including vasodilatation of coronary arterioles, reduction of neutrophil activation and adherence to endothelial cells, inhibition of platelet aggregation and thromboxane release, and alteration of intracellular nucleotide and calcium concentrations.21,23-25 Intravenous adenosine produced a twofold to threefold increase in the flow in all layers of the myocardium in both ischemic and nonischemic zones. Flow in the nonischemic zone in treated animals was only slightly elevated compared with flow in control animals 30 minutes after discontinuing adenosine. In contrast, flow in the ischemic zone remained markedly increased compared with control animals, which demonstrated a progressive decrease in endocardial and midmyocardial flows in the ischemic zone during the first 3 hours of reperfusion. This suggests that adenosine attenuated the no-reflow phenomenon, possibly by inhibiting vasospasm, platelet aggregation, and/or vascular obstruction by neutrophil plugs. Our results are entirely consistent with the finding of Engler,38 who showed that pretreatment with 5 -amino-4 imidazole carboxamide-riboside (AICA-riboside), a compound that augments adenosine release from ischemic myocytes, significantly improved regional myocardial blood flow after 60 minutes of regional ischemia in the dog. injury on a 0-6 scale (see Table 1 ). Note striking preservation ofendothelial ultrastructure in epicardial region and a tendency toward endothelial cellpreservation in endocardium of adenosine-treated animals. Right panel: Plot demonstrating degree ofmyocyte injury on a 0-2 scale (see Table 1 ). There were no differences between groups in either endocardial or epicardial region.
The reason for the persistent elevation in blood flow in the nonischemic zone 30 minutes after discontinuation of adenosine is unclear; one possibility is that adenosine suppressed renin release.39 Because renin has a half-life of 15-90 minutes, the increased blood flow may be due to reduced circulating renin levels. Other potential mechanisms include changes in sympathetic nerve reflexes in the coronary vasculature or alterations in myocardial oxygen demand.
Numerous studies support a role for the neutrophil in the pathogenesis of myocardial reperfusion injury.59,101940 In vitro studies have demonstrated that adenosine inhibits various neutrophil functions, including superoxide anion production, proteolytic enzyme release, neutrophil adherence, and cytotoxicity to cultured endothelial cells.23-25 A possible explanation for the protective effects of adenosine in the study may therefore be related to prevention of neutrophilmediated microvascular damage. This hypothesis is supported by ultrastructural changes that demonstrated extensive endothelial disruption with plugging of capillary lumina by endothelial cell debris and blood elements in control animals, whereas vascular plugging was infrequently observed in adenosine animals and was associated with relative preservation of endothelial cells. A study by Simpson et a136 demonstrated that a prolonged infusion of the prostacyclin analogue (iloprost) was required to permanently reduce myocardial reperfusion injury, whereas a relatively short infusion time of adenosine was highly effective in the present study. The reasons for this discrepancy are unknown but may be related to the different cellular effects of the two drugs. The pharmacological effects of adenosine are more complex than iloprost and involve both A, and A2 receptors.
Methodological Considerations
Numerous factors must be considered before these data can be extrapolated to the clinical situation. Abrupt occlusion of a normal canine coronary artery allows for only a crude comparison to humans, in whom infarction occurs due to gradual thrombotic occlusion of a chronically diseased coronary artery. Richard et a141 have demonstrated that a residual critical stenosis at the time of reperfusion abolishes reactive hyperemia but does not alter neutrophil infiltration 60 minutes after reperfusion or the extent of lethal reperfusion injury. Infarct size is also highly variable in the canine model and is dependent on the extent of collaterals between the LAD and the left circumflex vessels. We evaluated collateral blood flow in all animals and found that the two groups were comparably ischemic. Although the drug was effective over a broad range of collateral flows, producing a +52% reduction in infarct size for the total group, analysis of a subgroup of animals with severe ischemia (transmural blood flow <0.5 ml/g/ min) demonstrated an even more striking reduction (+t80%) in infarct size in the treated group. This is consistent with other studies demonstrating that reperfusion injury tends to be greater in hearts exposed to more severe ischemia. 3, 36 Therapeutic doses of lidocaine were used in both groups during occlusion and for the first 30 minutes of reperfusion. There are reports suggesting that large doses of lidocaine may alter neutrophil function and reduce infarct size.42-45 A preliminary report suggested that adenosine was only beneficial in attenuating reperfusion injury when administered with lidocaine. 46 However, in previous studies using a similar therapeutic dose of lidocaine, we have shown that significant neutrophil activation occurs during the first 24 hours of reperfusion, as manifested by enhanced neutrophil chemotaxis, and augmented lysozyme degranulation.5,47 Further studies are necessary to determine whether the beneficial effects of adenosine are dependent on the concomitant administration of lidocaine.
Implications
In this era of early reperfusion of acute myocardial infarction, infarct size reduction may be limited by deleterious events occurring at the time of reperfusion-myocardial reperfusion injury. The present study demonstrates that the intravenous administration of adenosine during the reperfusion period after 90 minutes of regional ischemia resulted in a persistent reduction in infarct size; this was associated with enhanced regional contractile function. Results of the present study corroborate previous research in our laboratory that reperfusion injury contributes significantly to infarct size in the canine model after 90 minutes of ischemia and that it is attenuated by intravenous adenosine. Regardless of whether myocyte salvage was due to abolition of the no-reflow phenomenon, improved postreperfusion blood flow may provide other beneficial effects such as increasing scar thickness, accelerating postinfarct ventricular remodeling and thereby reducing infarct expansion and aneurysm formation, and decreasing the incidence of ventricular arrhythmias.48-50 Further inquiry into the mechanisms of the beneficial effects of adenosine is warranted as well as studies assessing the clinical efficacy in humans in an attempt to limit infarct size and preserve left ventricular function beyond timely reperfusion alone.
